Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Biomedicines|March 29, 2023
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell LinesXuemei Xie, Jangsoon Lee, Jon A Fuson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in PlasmaDennis Wylie, Xiaoping Wang, Jun Yao, et al.
Breast Cancer Research and Treatment|October 18, 2019
Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancerToshiaki Iwase, Takafumi Sangai, Hiroshi Fujimoto, et al.
Science Advances|May 1, 2026
Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasmaDennis Wylie, Xiaoping Wang, Jun Yao, et al.
Molecular and Clinical Oncology|December 30, 2017
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin-bound paclitaxel for human epidermal growth factor receptor 2-negative breast cancerEmi Ishigami, Masahiro Sakakibara, Junta Sakakibara, et al.
Plos One|April 16, 2021
Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic reviewSudpreeda Chainitikun, Jose Rodrigo Espinosa Fernandez, James P Long, et al.
Biomedicines|July 2, 2021
PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi ScreeningJangsoon Lee, Huey Liu, Troy Pearson, et al.
Breast Cancer Research and Treatment|June 20, 2018
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesTakahiro Kogawa, Takeo Fujii, Tamer M Fouad, et al.
Cancers|October 13, 2021
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast CancerToshiaki Iwase, Kim R M Blenman, Xiaotong Li, et al.
Cancers|October 29, 2020
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast CancerKumiko Kida, Kenneth R Hess, Bora Lim, et al.
Pageof 4